152 related articles for article (PubMed ID: 28453910)
1. Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Aplenc R; Woods WG; Meshinchi S; Gamis AS
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28453910
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
[TBL] [Abstract][Full Text] [Related]
3. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Winick N; Devidas M; Chen S; Maloney K; Larsen E; Mattano L; Borowitz MJ; Carroll A; Gastier-Foster JM; Heerema NA; Willman C; Wood B; Loh ML; Raetz E; Hunger SP; Carroll WL
J Clin Oncol; 2017 Aug; 35(22):2527-2534. PubMed ID: 28535084
[TBL] [Abstract][Full Text] [Related]
4. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.
Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Algamal A; Felimban S
Hematology; 2019 Dec; 24(1):369-377. PubMed ID: 30885098
[TBL] [Abstract][Full Text] [Related]
6. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
Jastaniah W; Elimam N; Abdalla K; Khattab TM; Felimban S; Abrar MB
Hematology; 2015 Dec; 20(10):561-6. PubMed ID: 26010408
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.
Abbott BL; Rubnitz JE; Tong X; Srivastava DK; Pui CH; Ribeiro RC; Razzouk BI
Leukemia; 2003 Nov; 17(11):2090-6. PubMed ID: 14523477
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
[TBL] [Abstract][Full Text] [Related]
10. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2012 Apr; 58(4):519-24. PubMed ID: 21618422
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons.
Marwaha RK; Kulkarni KP; Bansal D; Trehan A
Leuk Lymphoma; 2010 Feb; 51(2):261-8. PubMed ID: 20038226
[TBL] [Abstract][Full Text] [Related]
12. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
Del Principe MI; Buccisano F; Soddu S; Maurillo L; Cefalo M; Piciocchi A; Consalvo MI; Paterno G; Sarlo C; De Bellis E; Zizzari A; De Angelis G; Fraboni D; Divona M; Voso MT; Sconocchia G; Del Poeta G; Lo-Coco F; Arcese W; Amadori S; Venditti A
Semin Hematol; 2018 Oct; 55(4):209-214. PubMed ID: 30502849
[TBL] [Abstract][Full Text] [Related]
13. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
[TBL] [Abstract][Full Text] [Related]
14. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
[TBL] [Abstract][Full Text] [Related]
15. High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia.
Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Aseeri M; Felimban S
Leuk Res Rep; 2018; 10():44-51. PubMed ID: 30416957
[TBL] [Abstract][Full Text] [Related]
16. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
Clin Cancer Res; 2015 Jul; 21(14):3187-95. PubMed ID: 25825478
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia.
Tang X; Mai H; Wang L; Chen S; Chen F; Li T; Liu Y; Zhou G; Liu S; Wang Y; Liu S; Fu X; Wen F
BMC Pediatr; 2024 Mar; 24(1):204. PubMed ID: 38519960
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Gossai NP; Devidas M; Chen Z; Wood BL; Zweidler-McKay PA; Rabin KR; Loh ML; Raetz EA; Winick NJ; Burke MJ; Carroll AJ; Esiashvili N; Heerema NA; Carroll WL; Hunger SP; Dunsmore KP; Winter SS; Teachey DT
Blood; 2023 Apr; 141(15):1802-1811. PubMed ID: 36603187
[TBL] [Abstract][Full Text] [Related]
19. CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
Pollard JA; Loken M; Gerbing RB; Raimondi SC; Hirsch BA; Aplenc R; Bernstein ID; Gamis AS; Alonzo TA; Meshinchi S
J Clin Oncol; 2016 Mar; 34(7):747-55. PubMed ID: 26786921
[TBL] [Abstract][Full Text] [Related]
20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]